Ace the CPFT Challenge 2026 – Breathe Easy with Pulmonary Success!

The lung volume test is essential in differentiating between restrictive and obstructive lung diseases because it provides direct measurements of the total lung capacity (TLC), functional residual capacity (FRC), and residual volume (RV).

In restrictive lung disease, the total lung capacity is reduced due to conditions that restrict lung expansion, such as fibrosis or chest wall deformities. Patients will typically show normal flows but reduced volumes on a lung volume test.

Conversely, in obstructive lung disease, such as chronic obstructive pulmonary disease (COPD) or asthma, the lung volumes can be normal or increased due to air trapping even though airflow is reduced. The measurements obtained from lung volume tests allow clinicians to accurately classify the type of lung disease.

While spirometry is a common tool used to assess lung function by measuring airflow rates, and the bronchodilator response test evaluates the reversibility of airway obstruction, both primarily provide information on airflow rather than differentiating lung volumes specifically. Plethysmography, while it can measure lung volumes, does so in a more complex manner that may not be as straightforward for classification purposes alone. Therefore, the lung volume test remains the specific and most appropriate choice for distinguishing between restrictive and obstructive lung conditions.